Abstract:beta-Arrestinl and beta-arrestin2 play a key role in the regulation of G protein-coupled receptor-mediated signaling, whereas the subcellular distribution of beta-arrestin1 and beta-arrestin2 has been shown to be quite different. In this study, we found that although both beta-arrestin1 and beta-arrestin2 are able to interact with ubiquitin-protein isopeptide ligase (E3) Mdm2, only expression of beta-arrestin2 leads to the relocalization of Mdm2 from the nucleus to the cytoplasm. Further study reveals that beta-arrestin2 but not beta-arrestin1 shuttles between the cytoplasm and nucleus in a leptomycin B-sensitive manner. A hydrophobic amino acid-rich region (VXXX-LXL) at the C terminus of beta-arrestin2 was further demonstrated to serve as a nuclear export signal responsible for the extranuclear localization of beta-arrestin2. In the corresponding region of beta-arrestin1, there is a single amino acid difference (Glu instead of Leu. in beta-arrestin2), and mutation of Glu to Leu conferred to beta-arrestin1 similar subcellular distribution to that of beta-arrestin2. Moreover, data from a series of deletion mutations demonstrated that the N domain (residues 1-185) was indispensable for the nuclear localization of both beta-arrestins, and the results from a Val to Asp point mutation in the N domain also supported this notion. In addition, our data showed that nucleocytoplasmic shuttling of beta-arrestin2 was required, via protein/protein interaction, for the cytoplasmic relocalization of Mdm2 and JNK3, another well known beta-arrestin2-binding protein. Our study thus suggests that both the nuclear export signal motif and the N domain of beta-arrestins are critical for the regulation of their subeellular localization and that beta-arrestin2 may modulate the function of its binding partners such as Mdm2 and JNK3 by alteration of their subcellular distribution.

The Ubiquitination of Arrestin3 within the Nucleus Triggers the Nuclear Export of Mdm2, Which, in Turn, Mediates the Ubiquitination of GRK2 in the Cytosol

Phospho-selective Mechanisms of Arrestin Conformations and Functions Revealed by Unnatural Amino Acid Incorporation and 19F-NMR

Visual and Both Non-visual Arrestins in Their “inactive” Conformation Bind JNK3 and Mdm2 and Relocalize Them from the Nucleus to the Cytoplasm*

Arrestin mobilizes signaling proteins to the cytoskeleton and redirects their activity.

Arrestin‐dependent Mobilization of Signaling Proteins to the Cytoskeleton

Subcellular Localization Of Beta-Arrestins Is Determined By Their Intact N Domain And The Nuclear Export Signal At The C Terminus

A Nuclear Function of β-Arrestin1 in GPCR Signaling: Regulation of Histone Acetylation and Gene Transcription

GPCR kinase subtype requirements for arrestin-2 and -3 translocation to the type-1 cannabinoid receptor and the consequences on G protein signalling

How Arrestin Assembles Map Kinases into A Signaling Complex

A Complex Structure of Arrestin-2 Bound to a G Protein-Coupled Receptor

Cone Arrestin Binding to JNK3 and Mdm2: Conformational Preference and Localization of Interaction Sites

The role and mechanism of β-arrestin2 in signal transduction

Progress studing in the role of arrestins

Unveiling the intracellular dynamics of α4β2 nAChR-mediated ERK activation through the interplay of arrestin, Gβγ, and PKCβII

The Two Non-Visual Arrestins Engage ERK2 Differently

Allosteric mechanisms underlie GPCR signaling to SH3-domain proteins through arrestin

Structural Mechanism of the Arrestin-3/JNK3 Interaction.

Beta-Arrestin 2 Functions As A G-Protein-Coupled Receptor-Activated Regulator Of Oncoprotein Mdm2

Scaffolding mechanism of arrestin-2 in the cRaf/MEK1/ERK signaling cascade

Insight into the regulatory mechanism of β-arrestin2 and its emerging role in diseases

Phosphorylation-dependent conformational changes of arrestin in the rhodopsin-arrestin complex